As reported at IDWeek 2023 and in The Lancet Diabetes & Endocrinology, people taking semaglutide experienced notable declines in weight, total body fat and visceral abdominal fat, while those in the placebo group saw little change or slight gains
This could lead to lower prices due to increased competition, greater accessibility in developing countries, and wider availability across pharmacies and healthcare systems
We were then interested in how this protective phenotype can be mitigated in ascites-exposed cells
The interplay between diet and the gut microbiome: implications for health and disease
These results remained unpublished until 2014, when we could supplement these findings with gene data
Most GLP-1 medications, including those used in programs we support, require refrigeration for long-term storage